A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy
Liyu Zhang,1,2 Meng Wang,3 Zeen Zhu,4 Chenxi Ding,1 Shengquan Chen,1 Haibin Wu,2 Ying Yang,2 Fengyu Che,2 Qiao Li,5 Hui Li1,6 1Department of Neonatology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 2Shaanxi Ins...
Guardado en:
Autores principales: | Zhang L, Wang M, Zhu Z, Ding C, Chen S, Wu H, Yang Y, Che F, Li Q, Li H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4aa184c025d143389f66c437f71f3540 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti I, et al.
Publicado: (2020) -
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
por: Keyel ME, et al.
Publicado: (2018) -
Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
por: Andrea M. Costello, et al.
Publicado: (2021) -
Monoclonal Antibody Therapies for High Risk Neuroblastoma
por: Furman WL
Publicado: (2021) -
Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects
por: Xie S, et al.
Publicado: (2021)